Skip to product information
1 of 1

Elabscience

SKU:PKSH033010

Recombinant Human Sclerostin/SOST Protein (His Tag)

Recombinant Human Sclerostin/SOST Protein (His Tag)

Regular price $178.00 USD
Regular price Sale price $178.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Introducing the Recombinant Human Sclerostin/SOST Protein (HIS TAG), a cutting-edge product designed to revolutionize the field of bone biology research. This meticulously engineered protein offers unparalleled quality and purity, making it an indispensable tool for scientists and researchers alike.

Crafted using state-of-the-art recombinant DNA technology, this product boasts a high level of homogeneity and stability, ensuring consistent and reliable results. The inclusion of a HIS tag further facilitates purification and detection, streamlining experimental procedures and enhancing efficiency.

The Recombinant Human Sclerostin/SOST Protein (HIS TAG) exhibits exceptional bioactivity, accurately mimicking the native protein's inhibitory effect on bone formation. This enables researchers to delve deeper into the intricate mechanisms underlying bone metabolism and explore potential therapeutic interventions for various skeletal disorders.

With its exceptional quality and reliability, this product is an invaluable asset for a wide range of applications, including in vitro and in vivo studies, drug discovery, and preclinical investigations. Its versatility and compatibility with various experimental systems make it an indispensable tool for researchers in the fields of bone biology, orthopedics, and regenerative medicine.

In summary, the Recombinant Human Sclerostin/SOST Protein (HIS TAG) represents a breakthrough in bone biology research, offering unrivaled purity, stability, and bioactivity. Its seamless integration into experimental workflows and its potential to unravel the complexities of bone metabolism make it an indispensable resource for scientists striving to advance our understanding of skeletal health and develop novel therapeutic strategies.
View full details